HIGHLIGHTS
- What: Conceptualization, Supervision, Writing-review and editing, Resources.
- Who: SCH et al. from the Nanjing Medical, China have published the research work: CRISPR-Cas9 screening develops an epigenetic and transcriptional gene signature for risk strati fi cation and target prediction in neuroblastoma, in the Journal: (JOURNAL)
- How: To address these challenges the authors conducted an integrative analysis using CRISPR-Cas9 knockout screening and other NB transcriptomic methods to develop an EP-TF gene signature providing a new diagnostic and prognostic tool. To further elucidate the role these 35 pivotal EP-TF genes in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.